Effective strategies for maintaining research participation in clinical trials

Drug Information Journal

Volumn 43, Issue 4, 2009, Pages 459-467

  Zweben, Allen ^a   Fucito, Lisa M ^c   O'Malley, Stephanie S ^b  

^a Mail Code 4600 ^*  (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

Alcohol and substance dependence; Clinical trial; Research retention

Indexed keywords

ALCOHOLISM; CLINICAL PROTOCOL; CLINICAL TRIAL; FOLLOW UP; HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RESEARCH SUBJECT; REVIEW; SUBSTANCE ABUSE;

EID: 68549120946     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150904300411     Document Type: Review

References (45)

1. Sibbald B, Roland M. Understanding controlled trials: why are randomised controlled trials important? Br Med J. 1998;316(7126):201.
2. Cramer J, Spilker B. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press; 1991.
3. Friedman L, Furburg C, DeMets D. Fundamentals of Clinical Trials. New York: Springer-Verlag; 1998.
4. Spilker B, Cramer J. Patient Recruitment in Clinical Trials. New York: Raven Press; 1992.
5. Moyer A, Finney J, Swearingen C. Methodological characteristics and quality of alcohol treatment outcome studies, 1970-1998: an expanded evaluation. Addiction. 2002;97(3):253-263.
6. Pich J, Carne X, Arnaiz J, Gomez B, Trilla A, Rodes J. Role of a research ethics committee in follow-up and publication of results. Lancet. 2003;361:1015-1016. (Pubitemid 36351372)
7. Wittes R, Friedman M. Accrual to clinical trials. J Natl Cancer Inst. 1988;80(12):884-885.
8. Easterbrook P, Matthews D. Fate of research studies. J R Soc Med. 1992;85(2):71-76.
9. Edwards A, Rollnick S. Outcome studies of brief alcohol intervention in general practice: the problem of lost subjects. Addiction. 1997;12:1699-1704. (Pubitemid 28006038)
10. Howard K, Cox W, Saunders S. Attrition in substance abuse comparative research: the illusion of randomization. NIDA Research Monograph. 1990;104:68-79.
11. Mattson M, DelBoca F, Carroll K, et al. Compliance with treatment and follow-up protocols Project MATCH: predictors and relationship to outcome. Alcohol: Clin Exp Res. 1998;22(6):1328-1339. (Pubitemid 28443158)
12. Thomson C, Morley K, Teesson M, Sannibale C, Haber P. Issues with recruitment to randomised controlled trials in the drug and alcohol field: a literature review and Australian case study. Drug Alcohol Rev. 2008;27(2):115-122.
13. Carroll K, ed. Enhancing Retention in Clinical Trials of Psychosocial Treatments: Practical Strategies. Washington, DC: Government Printing Office; 1997.
14. Onken L, Blaine J, Boren J, eds. Beyond the Therapeutic Alliance: Keeping the Drug-Dependent Individual in Treatment. NIDA Research Monograph No. 165. DHHS Publication No. (ADM) 97-4142; No. 165.
15. Group PMR. Project MATCH: rationale and methods for a multisite clinical trial matching alcoholism patients to treatment. Alcohol Clin Exp Res. 1993;17(6):1130-1145.
16. Zweben A, Barrett D, Berger L, Murray K. Recruiting and retaining participants in a combined behavioral and pharmacological clinical trial. J Stud Alcohol. 2005;66(Suppl. 15):72-81. (Pubitemid 41193180)
17. Flick S. Managing attrition in clinical research. Clin Psychol Rev. 1988;8:499-515.
18. Atwood J, Haase J, Rees-McGee S, et al. Reasons related to adherence in community-based field studies. Patient Educ Counsel. 1992;19(3):251-259.
19. Bender B, Ellison M, Gleason M, Murphy J, Sundstrom D, Szefler S. Minimizing attrition in a long-term clinical trial of pediatric asthma. Ann Allergy Asthma Immunol. 2003;91:168-176.
20. Cassidy E, Baird E, Sheikh J. Recruitment and retention of elderly patients in clinical trials. Am J Ger Psychiatry. 2001;9:136-140. (Pubitemid 32298867)
21. Moser D, Dracup K, Doering L. Factors differentiating dropouts from completers in a longitudinal, multicenter clinical trial. Nurs Res. 2000;49(2):109-116.
22. May D, Kratochvil C, Puumala S, Silva S, Rezac A, Hallin M. A manual based intervention to address clinical crises and retain patients in the treatment of adolescents with depression study (TADS). J Am Acad Child Adolesc Psychiatry. 2006;46(5):573-581.
23. Cottler L, Compton W, Ben-Abdallah A, Horne M, Claverie D. Achieving a 96.6 percent follow-up rate in a longitudinal study of drug abusers. Drug Alcohol Depend. 1996;41:209-217. (Pubitemid 26252463)
24. Scott C. A replicable model for achieving over 90% follow-up rates in longitudinal studies of substance abusers. Drug Alcohol Depend. 2004; 74:21-36. (Pubitemid 38457050)
25. Callaghan R, Hathaway A, Cunningham J, Vettese L, Wyatt S, Taylor L. Does stage-of-change predict dropout in a culturally diverse sample of adolescents admitted to inpatient substance abuse treatment? A test of the transtheoretical model. Addict Behav. 2005;30:1834-1847. (Pubitemid 41443318)
26. DiClemente C, Schlundt D, Gemmell L. Readiness and stages of change in addiction treatment. Am J Addict. 2004;13(2):103-119.
27. Dickert N, Grady C. What's the price of a research subject? Approaches to payment for research participation. N Engl J Med. 1999;341(3):198-203. (Pubitemid 29325751)
28. Fry C, Dwyer R. For love or money? An exploratory study of why injecting drug users participate in research. Addiction. 2001;96:1319-1325. (Pubitemid 32835709)
29. Koocher G. Questionable methods in alcoholism research. J Consult Clin Psychol. 1991;59(2):246-248.
30. McGee G. A piece of my mind. Subject to payment? JAMA. 1997;278(3):199-200.
31. McKeganey N. To pay or not to pay: respondents' motivation for participating in research. Addiction. 2001;96:1237-1238. (Pubitemid 32835699)
32. Shaner A, Eckman T, Robert L, et al. Disability income, cocaine use, and repeated hospitalization among schizophrenic cocaine abusers - a government sponsored revolving door? N Engl J Med. 1995;333:777-783.
33. Cunningham J, Sobell L, Chow V. What's in a label? The effects of substance types and labels on treatment considerations and stigma. J Stud Alcohol. 1993;54(6):693-699. (Pubitemid 23318741)
34. Mark T, Kranzler H, Poole V, Hagen C, McLeod C, Crosse S. Barriers to the use of medications to treat alcoholism. Am J Addict. 2003;12(4):281-294. (Pubitemid 37175521)
35. Anton R, O'Malley S, Ciraulo D, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence. The COMBINE Study: a randomized controlled trial. JAMA. 2006;295:2003-2017. (Pubitemid 44794003)
36. Desmond D, Maddux J, Johnson T, Confer B. Obtaining follow-up interviews for treatment evaluation. J Subst Abuse Treat. 1995;12(2):95-102.
37. McCrady B, Bux D. Ethical issues in informed consent with substance abusers. J Clin Invest. 1999;67:186-193. (Pubitemid 29206766)
38. Grady C. Payment of clinical research subjects. J Clin Invest. 2005;115:1681-1687.
39. Amass L, Bickel W, Crean J, Higgins S, Badger G. Preferences for clinic privileges, retail items and social activities in an outpatient treatment program. JSubst Abuse Treat. 1996;B(1):43-49. (Pubitemid 26112137)
40. Kurlander J, Simon-Dack S, Gorelick D. Spending of remuneration by subjects in non-treatment drug abuse research studies. Am J Drug Alcohol Abuse. 2006;32:527-540. (Pubitemid 44870990)
41. Festinger D, Marlowe D, Croft J, et al. Do research payments precipitate drug use or coerce participation? J Drug Alcohol Depend. 2005;78:275-281. (Pubitemid 40694049)
42. Miller W. Form 90: A Structured Assessment Interview for Drinking and Related Behaviors Test Manual. NIAAA Project MATCH Monograph Series. NIH Publication No. 96-4944. Vol 5. Bethesda, MD: Department of Health and Human Services; 1996.
43. Barrett D, Morse P, eds. Handling Noncompliance. Bethesda, MD: Department of Health and Human Services; 1998.
44. Zweben A, Barrett D, Carty K, McRee B, Morse P, Rice C, eds. Strategies for Facilitating Protocol Compliance in Alcoholism Treatment Research. NIAAA Project MATCH Monograph Series. NIH Publication No. 98-4144. Bethesda, MD: Department of Health and Human Services; 1998; No.7.
45. McRee B, ed. Project MATCH: A Case Study. Bethesda, MD: Department of Health and Human Services; 1998.